Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
STTK Shattuck Labs
- 1.330
- +0.080+6.40%
Close Feb 14 16:00 ET
- 1.370
- +0.040+3.01%
Post 19:16 ET
63.49MMarket Cap-0.87P/E (TTM)
1.360High1.240Low132.77KVolume1.260Open1.250Pre Close173.86KTurnover0.49%Turnover RatioLossP/E (Static)47.74MShares11.76052wk High0.66P/B36.27MFloat Cap0.94052wk Low--Dividend TTM27.27MShs Float60.516Historical High--Div YieldTTM9.60%Amplitude0.940Historical Low1.309Avg Price1Lot Size
About Shattuck Labs Company
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Company Profile
SymbolSTTK
Company NameShattuck Labs
Listing DateOct 9, 2020
Issue Price17.00
Founded2016
CEODr. Taylor H. Schreiber, M.D.,PhD
MarketNASDAQ
Employees75
Fiscal Year Ends12-31
Address500 West 5th Street,Suite 1200
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78701
Phone1-512-900-4690
Websitehttp://www.shattucklabs.com
Company Executives
- Name
- Position
- Salary
- Dr. Taylor H. Schreiber, M.D.,PhD
- Chief Executive Officer and Director
- --
- Casi DeYoung
- Chief Business Officer
- --
- Dr. Arundathy Nirmalini Pandite, MB.Ch.B.
- Chief Medical Officer
- --
- Andrew R. Neill
- Chief Financial Officer and Principal Accounting Officer
- --
- Abhinav A. Shukla
- Chief Technical Officer
- --
- Stephen Stout
- Deputy General Counsel and Vice President of Intellectual Property
- --
- Dr. George Golumbeski, PhD
- Chairman of the Board
- --
- Dr. Clay B. Siegall,PhD
- Director
- --
- Dr. Kate Sasser, PhD
- Director
- --
- Helen M. Boudreau, M.B.A.
- Independent Director
- --
- Dr. Neil Gibson,PhD
- Independent Director
- --
- Dr. Carrie Brownstein, M.D.
- Independent Director
- --
- Tyler Brous
- Independent Director
- --
- Michael Lee
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.